This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Robbins, B. L.
Right arrow Articles by Fridland, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Robbins, B. L.
Right arrow Articles by Fridland, A.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, 10 1995, 2304-2308, Vol 39, No. 10
Copyright © 1995 by the American Society for Microbiology. All rights reserved.

Metabolic pathways for activation of the antiviral agent 9-(2- phosphonylmethoxyethyl)adenine in human lymphoid cells

BL Robbins, J Greenhaw, MC Connelly and A Fridland
Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA.

9-(2-Phosphonylmethoxyethyl)adenine (PMEA), the acyclic phosphonate analog of adenine monophosphate, is a promising antiviral drug with activity against herpesviruses, Epstein-Barr virus, and retroviruses, including the human immunodeficiency virus. In order to be active, it must be converted to the diphosphate derivative, the putative inhibitor of viral DNA polymerases. The metabolic pathway responsible for activation of PMEA is unclear. The metabolism of PMEA was investigated in human T-lymphoid cells (CEMss) and a PMEA-resistant subline (CEMss(r- 1)) with a partial deficiency in adenylate kinase activity. Experiments with [3H]PMEA showed that extracts of CEMss phosphorylated PMEA to its mono- and diphosphate in the presence of ATP as the phosphate donor. No other nucleotides or 5-phosphoribosyl pyrophosphate displayed appreciable activity as a phosphate donor. Subcellular fractionation experiments showed that CEMss cells contained two nucleotide kinase activities, one in mitochondria and one in the cytosol, which phosphorylated PMEA. The PMEA-resistant CEMss mutant proved to have a deficiency in the mitochondrial adenylate kinase activity, indicating that this enzyme was important in the phosphorylation of PMEA. Other effective antiviral purine phosphonate derivatives of PMEA showed a profile of phosphorylating activity similar to that of PMEA. By comparison, phosphorylation of the pyrimidine analog (S)-1-(3-hydroxy-2- phosphonylmethoxypropyl) cytosine proceeded by an enzyme present in the cytosol. We conclude from these studies that adenylate kinase which has been localized in the intermembrane space of mitochondria is the major route for PMEA phosphorylation in CEMss cells but that another hitherto unidentified enzyme(s) present in the cytosol may contribute to the anabolism of the phosphonates.


This article has been cited by other articles:

  • Birkus, G., Kutty, N., He, G.-X., Mulato, A., Lee, W., McDermott, M., Cihlar, T. (2008). . Mol. Pharmacol. 74: 92-100 [Abstract] [Full Text]  
  • Ray, A. S., Vela, J. E., Boojamra, C. G., Zhang, L., Hui, H., Callebaut, C., Stray, K., Lin, K.-Y., Gao, Y., Mackman, R. L., Cihlar, T. (2008). Intracellular Metabolism of the Nucleotide Prodrug GS-9131, a Potent Anti-Human Immunodeficiency Virus Agent. Antimicrob. Agents Chemother. 52: 648-654 [Abstract] [Full Text]  
  • Basavapathruni, A., Anderson, K. S. (2007). Reverse transcription of the HIV-1 pandemic. FASEB J. 21: 3795-3808 [Abstract] [Full Text]  
  • Marchand, B., White, K. L., Ly, J. K., Margot, N. A., Wang, R., McDermott, M., Miller, M. D., Gotte, M. (2007). Effects of the Translocation Status of Human Immunodeficiency Virus Type 1 Reverse Transcriptase on the Efficiency of Excision of Tenofovir. Antimicrob. Agents Chemother. 51: 2911-2919 [Abstract] [Full Text]  
  • Birkus, G., Wang, R., Liu, X., Kutty, N., MacArthur, H., Cihlar, T., Gibbs, C., Swaminathan, S., Lee, W., McDermott, M. (2007). Cathepsin A Is the Major Hydrolase Catalyzing the Intracellular Hydrolysis of the Antiretroviral Nucleotide Phosphonoamidate Prodrugs GS-7340 and GS-9131. Antimicrob. Agents Chemother. 51: 543-550 [Abstract] [Full Text]  
  • Imaoka, T., Kusuhara, H., Adachi, M., Schuetz, J. D., Takeuchi, K., Sugiyama, Y. (2007). Functional Involvement of Multidrug Resistance-Associated Protein 4 (MRP4/ABCC4) in the Renal Elimination of the Antiviral Drugs Adefovir and Tenofovir. Mol. Pharmacol. 71: 619-627 [Abstract] [Full Text]  
  • Dallas, S., Schlichter, L., Bendayan, R. (2004). Multidrug Resistance Protein (MRP) 4- and MRP 5-Mediated Efflux of 9-(2-Phosphonylmethoxyethyl)adenine by Microglia. J. Pharmacol. Exp. Ther. 309: 1221-1229 [Abstract] [Full Text]  
  • Grim, S. A, Romanelli, F. (2003). Tenofovir Disoproxil Fumarate. The Annals of Pharmacotherapy 37: 849-859 [Abstract] [Full Text]  
  • McColl, D. J., Miller, M. D. (2003). The use of tenofovir disoproxil fumarate for the treatment of nucleoside-resistant HIV-1. J Antimicrob Chemother 51: 219-223 [Full Text]  
  • Birkus, G., Hajek, M., Kramata, P., Votruba, I., Holy, A., Otova, B. (2002). Tenofovir Diphosphate Is a Poor Substrate and a Weak Inhibitor of Rat DNA Polymerases {alpha}, {delta}, and {varepsilon}. Antimicrob. Agents Chemother. 46: 1610-1613 [Abstract] [Full Text]  
  • Kramata, P., Downey, K. M. (1999). 9-(2-Phosphonylmethoxyethyl) Derivatives of Purine Nucleotide Analogs: A Comparison of Their Metabolism and Interaction with Cellular DNA Synthesis. Mol. Pharmacol. 56: 1262-1270 [Abstract] [Full Text]  
  • Palmer, S., Shafer, R. W., Merigan, T. C. (1999). Hydroxyurea Enhances the Activities of Didanosine, 9-[2-(Phosphonylmethoxy)ethyl]adenine, and 9-[2-(Phosphonylmethoxy)propyl]adenine against Drug-Susceptible and Drug-Resistant Human Immunodeficiency Virus Isolates. Antimicrob. Agents Chemother. 43: 2046-2050 [Abstract] [Full Text]  
  • Hatse, S., De Clercq, E., Balzarini, J. (1998). Enhanced 9-(2-Phosphonylmethoxyethyl)adenine Secretion by a Specific, Indomethacin-Sensitive Efflux Pump in a Mutant 9-(2-Phosphonylmethoxyethyl)adenine-Resistant Human Erythroleukemia K562 Cell Line. Mol. Pharmacol. 54: 907-917 [Abstract] [Full Text]  
  • Miller, M. D., Lamy, P. D., Fuller, M. D., Mulato, A. S., Margot, N. A., Cihlar, T., Cherrington, J. M. (1998). Human Immunodeficiency Virus Type 1 Reverse Transcriptase Expressing the K70E Mutation Exhibits a Decrease in Specific Activity and Processivity. Mol. Pharmacol. 54: 291-297 [Abstract] [Full Text]  
  • Mulato, A. S., Lamy, P. D., Miller, M. D., Li, W.-X., Anton, K. E., Hellmann, N. S., Cherrington, J. M. (1998). Genotypic and Phenotypic Characterization of Human Immunodeficiency Virus Type 1 Variants Isolated from AIDS Patients after Prolonged Adefovir Dipivoxil Therapy. Antimicrob. Agents Chemother. 42: 1620-1628 [Abstract] [Full Text]  
  • Arts, E. J., Quinones-Mateu, M. E., Albright, J. L., Marois, J.-P., Hough, C., Gu, Z., Wainberg, M. A. (1998). 3'-Azido-3'-Deoxythymidine (AZT) Mediates Cross-Resistance to Nucleoside Analogs in the Case of AZT-Resistant Human Immunodeficiency Virus Type 1 Variants. J. Virol. 72: 4858-4865 [Abstract] [Full Text]  
  • Robbins, B. L., Srinivas, R. V., Kim, C., Bischofberger, N., Fridland, A. (1998). Anti-Human Immunodeficiency Virus Activity and Cellular Metabolism of a Potential Prodrug of the Acyclic Nucleoside Phosphonate 9-R-(2-Phosphonomethoxypropyl)adenine (PMPA), Bis(isopropyloxymethylcarbonyl)PMPA. Antimicrob. Agents Chemother. 42: 612-617 [Abstract] [Full Text]  
  • Pisarev, V. M., Lee, S.-H., Connelly, M. C., Fridland, A. (1997). Intracellular Metabolism and Action of Acyclic Nucleoside Phosphonates on DNA Replication. Mol. Pharmacol. 52: 63-68 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»